DERIVATIVES OF NONAPEPTIDES OR THEIR SALTS WITH PHARMACEUTICALLY ACCEPTABLE ACIDS, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION Russian patent published in 1998 - IPC

Abstract RU 2115659 C1

FIELD: chemistry of peptides, medicine. SUBSTANCE: derivatives of nonapeptides of the general formula (I): X-A1-A2-Trp-Ala-Val-Gly-His-Leu-psi TriQ where Q is OMe, NH2; X is hydrogen, acetyl, CONH2; A1 is D- or L-Tpi, D-p-Glu; A2 is Gln, Glu(OMe), Glu(MeNH), Glu, His(Bz) or the formula (II): D-Tpi-A2-Trp-Ala-Val-Gly-His-Leu-psiA9NH2 where A2 is Gln, Glu(OMe), His, His(Bz); A9 is Leu, Phe, Trp, Trp(For) or their salts with pharmaceutically acceptable acids. Peptides are synthesized by step splicing of peptide chain. Amino-group at α-position is protected and terminal carboxy-group is bound covalently with synthetic polymeric carrier used for this purpose. Then α-protective group is split off, carboxy-group of the next amino acid is reduced to group HC=O and the latter is bound with the above mentioned α-amino-group deblocked preliminary. Then α-amino-protective group of this second amino acid is deblocked and carboxy-group of the next amino acid is bound with above mentioned deblocked α-amino-group of the second amino acid. Then other amino acid are bound to sequence corresponding the structural formula (I) or (II). From obtained peptidylpolymer carrier is split off and if necessary protective groups also. Obtained peptides if necessary are acetylated and the end product is isolated in free form or as a salt with pharmaceutically acceptable acid. Pharmaceutical composition has an active component (compound of the formula I) taken at effective dose and pharmaceutically acceptable carrier. Synthesized compounds show antagonistic activity with respect to bombazine and can be used in medicine for therapy of malignant diseases in animals and human. EFFECT: improved method of synthesis, enhanced effectiveness. 19 cl, 2 tbl, 6 ex

Similar patents RU2115659C1

Title Year Author Number
PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE ACIDS OR SALTS, PHARMACEUTICAL COMPOSITION SHOWING ANTAGONISTIC ACTIVITY WITH RESPECT TO BOMBESINE, METHOD OF TREATMENT OF MAMMALIAN WITH CANCER 1994
  • Ehndrju V.Skehlli
  • Ren Zhi Kehj
RU2114118C1
THERAPEUTIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS 1989
  • Dehvid Kh.Koj[Us]
  • Zhak-P'Er Moro[Us]
  • Dzhon E.Tejlor[Us]
  • Sun Kh'Juk Kim[Us]
RU2088592C1
PEPTIDE OR ITS ORGANIC OR INORGANIC SALTS, METHOD OF SYNTHESIS, PHARMACEUTICAL COMPOSITION, METHODS OF GROWTH HORMONE RELEASE STIMULATION AND ITS BLOOD CONTENT INCREASE 1992
  • Kirill J. Bauehrs
  • Dehvid Koj
RU2126014C1
ANTAGONISTIC ANALOGUES OF GROWTH HORMONE RELEASING-HORMONE (GH-RH) INHIBITING INSULIN-LIKE GROWTH FACTORS (IGF-I AND -II) 1999
  • Shehlli Ehndrju V.
  • Varga Dzhozef
  • Zarandi Marta
RU2235099C2
PEPTIDE ANALOGUES GH-RH WITH OPPOSING ACTION, WAY OF DEPRESSION OF GH LEVEL, WAY OF DEPRESSION OF IGF-INIGF-II LEVEL, APPLICATION FOR INHIBITION OF GROWTH OF CANCER CELLS, PHARMACOLOGICALLY ACCEPTABLE COMPOSITION (VARIANTS) 2004
  • Shelli Ehndrju V.
  • Varga Jozhef
  • Zarandi Marta
  • Tsaj Zhehn' Chzhi
RU2335506C2
SOMATOSTATIN RECEPTOR ANTAGONISTS 1997
  • Morgan Behrri
  • Merfi Vill'Jam
  • Koj Dehvid Kh.
RU2179172C2
GLP-1 ANALOGUES 1999
  • Dong Zheng Ksin
  • Koj Dehvid Kh.
RU2208015C2
SOMATOSTATIN AGONISTS 2002
  • Koj Dehvid Kh.
  • Radzhesvaran Valadzhapet G.
RU2259375C2
UROTENSIN-II AGONISTS AND ANTAGONISTS 2001
  • Koj Dehvid Kh.
  • Rossovski Vojtsekh J.
RU2263679C2
SOMATOSTATIN ANTAGONISTS 2002
  • Koj Dehvid Kh.
  • Merfi Vill'Jam A.
  • Radzhesvaran Valadzhapet G.
RU2263678C2

RU 2 115 659 C1

Authors

Ehndrju V.Shelli

Ren Zi Kaj

Dates

1998-07-20Published

1991-11-15Filed